ALTIERI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 40
NA - Nord America 39
AS - Asia 11
AF - Africa 2
Totale 92
Nazione #
US - Stati Uniti d'America 39
IT - Italia 17
IE - Irlanda 13
SG - Singapore 7
FR - Francia 3
SE - Svezia 3
GB - Regno Unito 2
HK - Hong Kong 2
NG - Nigeria 2
AT - Austria 1
CN - Cina 1
FI - Finlandia 1
JP - Giappone 1
Totale 92
Città #
Dublin 13
Chandler 10
Turin 7
Singapore 4
Milan 3
Nyköping 3
Abuja 2
Saint-Fons 2
Ashburn 1
Beijing 1
Grugliasco 1
Helsinki 1
Hong Kong 1
Medford 1
Princeton 1
Quartu Sant'Elena 1
Rome 1
Seattle 1
Southampton 1
Stegersbach 1
Tokyo 1
Washington 1
Totale 58
Nome #
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study 37
Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa: A Review of Available Data 26
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis 14
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study 13
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis 6
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study 2
Totale 98
Categoria #
all - tutte 755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 0 4
2022/202347 1 3 1 6 5 11 6 2 5 0 3 4
2023/202444 7 7 3 5 1 3 1 1 3 3 4 6
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 98